India sailed through Omicron wave because of vaccination: Mandaviya

India effectively handled the Omicron wave, which caused numerous deaths in other countries, because of better Covid management and massive vaccination drive, Mandaviya said

Mansukh L Mandaviya
Mandaviya said the ICMR has from time to time guided the country and helped in vaccine-related research leading to India having its own indigenous vaccine. (PTI Photo)
Press Trust of India New Delhi
1 min read Last Updated : Apr 01 2022 | 12:55 PM IST

India effectively handled the Omicron wave, which caused numerous deaths in other countries, because of better Covid management and a massive vaccination drive, Health Minister Mansukh Mandaviya said on Friday.

Replying to a supplementary question in the Lok Sabha, Mandaviya said the ICMR has from time to time guided the country and helped in vaccine-related research leading to India having its own indigenous vaccine.

"It was under Prime Minister Narendra Modi's guidance that India saw best Covid management and largest vaccination drive... While Omicron caused numerous deaths in other countries, India sailed through the Omicron wave because of vaccination," Mandaviya said during the Question Hour.

India, which battled the deadly second wave blamed on the Delta variant in April-May last year, faced the Omicron challenge in December 2021-January 2022. However, the impact of Omicron in India was apparently less severe compared to the Delta variant.

The cumulative vaccine doses administered in the country so far under the nationwide COVID-19 vaccination drive has exceeded 184.31 crore.

India's indigenous Covid vaccine Covaxin is being manufactured by Bharat Biotech.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusOmicronMansukh Lal MandaviyaVaccination

First Published: Apr 01 2022 | 12:55 PM IST

Next Story